Skip to main content
. 2005 Sep 3;55(8):973–980. doi: 10.1007/s00262-005-0055-0

Table 1.

Patient and tumour characteristics (n=449)

Variable Category Total number Number (%) CD59 + Number (%) CD59 − p value
Gender
Male 257 41 (16) 216 (84) 0.127
Female 192 21 (10.9) 171 (89.1)
Tumour type
Adenocarcinoma 382 54 (14.1) 328 (85.9) 0.798
Mucinous carcinoma 49 7 (14.3) 42 (85.7)
Signet ring carcinoma 6 0 6 (100)
Columnar carcinoma 4 0 4 (100)
Unknown 8 1 (12.5) 7 (87.5)
Tumour grade
Well differentiated 28 8 (28.6) 20 (71.4) 0.017
Moderately differentiated 345 50 (14.5) 295 (85.5)
Poorly differentiated 67 3 (4.5) 64 (95.5)
Unknown 9 1 (11.1) 8 (88.9)
TNM stage
0 3 0 3 (100) 0.111
I 67 15 (22.4) 52 (77.6)
II 172 18 (10.5) 154 (89.5)
III 149 19 (12.8) 130 (87.2)
IV 51 10 (19.6) 41 (80.4)
Unknown 7 0 7 (100)
Tumour site
Colon 230 25 (10.9) 205 (89.1) 0.115
Rectal 177 28 (15.8) 149 (84.2)
Unknown 42 9 (21.4) 33 (78.6)
Vascular invasion status
Negative 219 22 (10) 197 (90) 0.074
Positive 121 22 (18.2) 99 (81.8)
Unknown 109 18 (16.5) 91 (83.5)